ChondroCelect
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ChondroCelect, covering 2010-01-18 to 2017-01-12. Get the full timeline:
Most recent: EMA Withdrawn: ChondroCelect (characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins) — TiGenix N.V.